Synthetic IL-10 analogues

Details Synthetic IL-10 analogues Synthetic IL-10 analogues

2005-08-30

2005-08-30

Kunz, Gary (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S008100, C514S012200, C514S013800, C514S014800, C424S085200, C530S300000, C530S317000, C530S328000

Reexamination Certificate

active

06936586

ABSTRACT:
The nonapeptide NH2-Ala-Tyr-Met-Thr-Met-Lys-Ile-Arg-Asn-COOH (SEQ ID NO: 1) and related molecules are useful as IL-10 agonists.

REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4837028 (1989-06-01), Allen
patent: 5446128 (1995-08-01), Kahn
patent: 5654276 (1997-08-01), Barrett et al.
patent: 2085291 (1992-12-01), None
patent: 9317698 (1993-09-01), None
patent: 9503411 (1995-02-01), None
Vieira et al, Proceedings of National Academy of Sciences, USA, vol. 88, pp. 1172-1176, Feb. 1991.
Koonce, M.P., et al., “Dynein fromDictyostelium: Primary Structure Comparisons Between a Cytoplasmic Motor Enzyme and Flagellar Dynein,”The Journal of Cell Biology119(6): 1597-1604 (1992).
Harlow, E., et al., “Antibodies That React with Predetermined Sites on Proteins,”Science219:660-666 (1983).
Sutcliffe, J.G., et al., “Antibodies That React with Predetermined Sites on Proteins,”SCIENCE219:660-666 (1983).
Rudinger, J., “Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence,”Peptide HormonesUniversity Park Press pp. 1-7 (1976).
Kimball, J.W., “Introduction to Immunology,” Macmillan Publishing Co., Inc., pp. 438-439 (1983).
Bendtzen K. Lymphokines in inflammation. Inflammation Basic Mechanisms Tissue Injuring Principles and Clinical Models (P Venge & A Lindbom eds) 1985; Almqvist & Wiksell International. Stockholm: 187-217.
Bendtzen K. Interleukin-1, Interleukin-6, and tumor necrosis factor in infection, inflammation and immunity, Immunol Lett 1988;19:183-192.
Larsen C.G. Leukocyte activating and chemotactic cytokines in cell-mediated immune reactions of the human skin. Acta Dermatovenerol. 1991; Suppl. 160:1-48.
Fiorentino D.F., M. W. Bond, and T.R. Mosmann. 1989. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th 1 clones. J. Exp. Med., 170:2081.
Viera P., R. de Wall-Malefyt, M.-N. Dang, K. E. Johnson, R. Kastelein, D. F. Fiorentiono, J. E. de Vries, M.-G. Roncarolo, T. R. Mosmann, and K. W. Moore. 1991. Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL-10) cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. (USA), 88:1172.
Moore, K.W., O'Garra A., de Waal Malefyt R., Vieira, Mosmann T.R. 1993. Interleukin-10, Annu Rev. Immunol, 11:165-90.
Kim, J.M., Brannan, C.I. Copeland N.G., Jenkins, N.A., Khan, T.A., Moore, K.W. 1992. Structure of the mouse interleukin-10 gene and chromosomal localization of the mouse and human genes. J. Immunol 148:3618-23.
Carter, D.B., Deibel, M.R-Jr, Dunn, C.J. et al. 1990. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344:633-638.
Hannum, C.H., Wilcox, C.J., Arend, W.P. et al. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-40.
Firestein, G.S., Boyle, D.L., Yu, C., et al. 1994. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37:644-652.
Fisher, C.J.-Jr.,Slotman, G.J., Opal, S.M., Pribble, J.P. et al. 1994. Initial evaluation of recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group. Crit-Care-Med. 22:12-21.
de Waal-Malefyt, R., Haanen J., Spits, H., et al. 1991. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-reulation of class II MHC expression. J. Exp. Med. 174:915-24.
Gazzinelli, R.T., Oswald, I.P., James, S.L., Sher, A., 1992. IL-10 inhibits parasite killing and nitric oxide production by IFN-\-activated macrophages. J. Immunol. 148:1792-96.
Jinquan, T., Larsen, C.G., Gesser, B., Matsushima, K., Thestrup-Pedersen, K. 1993.Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ lymphocyte Migration. Journal of Immunology, 151:4545-4551.
Rousset F., E. Garcia, T. Defrance, C. Peronne, D.-H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA, 175:671.
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., de Vries, J. 1992. Biological properties of Interleukin-10. J. Clin. Immunol 12:239-47.
Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-74.
Sher, A., Fiorentino, D.F., Caspar, P., Pearce, E., Mosmann, T. 1991. Production of IL-10 by CD4+ lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147:2713-16.
Clerici, M., Shearer, G.M. 1993 Immunology Today. 14:107-111.
Bry, K., Lappalainen, U. 1994. Interleukin-4 and transforming growth factor-beta 1 modulate the production of interleukin-1 receptor antagonist and prostaglandin E2 by decidual cells. Am-J-obstet-Gynecol 170 (4): 1194-1198.
Roberge, C. J., De-Medicis, R., Dayer, J. M., Rola-Pleszcyczynski, M., Naccahe, P. H., Poubelle, P. E. 1994. Crystal-induced neutrophil activation: V. Differential production of biologically active IL-1 receptor antagonist. J. Immunol 152/11: 5485-5494.
McCall, R. D., Haskill, S., Zimmermann, E. M., Lund, P. K., Thompson, R. C., Sartor, R. B. 1994. Tissue interluekin 1 and interleukin-1 receptor antagonist expression in entercolitis in resistant and susceptible rats. Gastroenterology (4): 960-72.
Kimble, R. B., Vannice, J. L., Bloedow, D. C., Thompson, R. C., Hopfer, W., Kung, V. T., Brownfield, C., Pacifici, R. 1994. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J. Clin Invest. 93/5: 1959-1967.
Kline, J. N., Geist, L. J., Monick, M. M., Stinski, M. F., Hunninghake, G. W., 1994. J. Immunol. 152 (5): 2351-7.
Tompkins, R. G. 1994. Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome (editorial; comment). Crit-Care-Med. 22 (1): 3, 22 (1): 12-21.
Everaedt, B., Brouckaert, P., Fiers, W. 1994. Recombination IL-1 receptor antagonist protects against TNF-induced lethality in mice. J. Immunol. 152/10: 5041-5049.
Fischer, C. J. Jr., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., Catalano, M. A. 1994. Initial evaluation of human recombination interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-IRA Sepsis Syndrome Study Group (see comments). Crit-Care-Med. 22(1): 12-21, 22(1): 3.
Gomez-Reino-Carnoto, J. J. 1994. New terapies in rheumatoid arthritis. Med-Clin 543-545. English Translation in Paper as Filed on Feb. 25, 1999.
Nishihara, T., Ohsaki, Y., Ueda, N., Saito, N., Mundy, G. R. 1994. Mouse interleukin-1 receptor antagonist induced by actinomycetem-comitans lipopolysaccharide blocks the effects of interleukin-1 om bone resorption and osteoclast-like cell formation. Infect-Immun. 62(2): 390-7.
Simon, C., Frances, A., Piquette, G. N., el-Danasouri, I., Zurawski, G., Dang, W., Polan, M. L. 1994. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist (see comments). Endocrinology. 134(2): 521-8, 134(2): 519-20.
Baergen, R., Benirschke, K., Ulich, T. R., 1994. Cytokine expression in the placenta. The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition. Arch-Pathol-Lab-Med. 118(1): 52-5.
Tang, W.W., Feng, L., Vannice, J. L., Wilson, C. B. 1994. Interleukin-1 receptor antagonist ameliorates experimental antiglomerular basement membrane antibody-associated flomeulonephritis. J. Clin-Invest. 93(1): 279-9.
Cassatella, M. A., Meda, L., Gasperini, S., Calzetti, F., Bonara, S. 1994.Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuc

Affiliated with

Also associated with

Rating

Synthetic IL-10 analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic IL-10 analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic IL-10 analogues will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3461644